The scope of experience of Polaris’s executive team spans nine decades & several fields, including military service, medicine, & federal research & development. These experiences have allowed the team to cultivate timely knowledge of pandemic-era mental health needs, & develop deeply unique qualifications to address these needs. The team has garnered numerous awards, ranks, titles, & accomplishments, ranging from captain to engineer, Purple Heart recipient to medical doctor, virologist & immunologist, 9/11 responder to Iraq War veteran, & PhD to Homeland Security Public Health Officer amid the threats of SARS & anthrax.
In 2017, inspired by their work at the Defense & Veterans Brain Injury Center & the US Department of Veterans Affairs, a veteran & a scientist coalesced their visions seeded in service around the urgent need for 21st-century innovation in behavioral healthcare. Drawing upon decades of experience in biomedical technology, public health, & molecular biology, they founded a company to take aim at the mental health crisis that results in 22 veteran suicides each day. Partnering with the Illumina Accelerator & scientists from Mount Sinai & the Max Planck Institute of Psychiatry, the team developed the first-to-market, patented genomic biomarker assay to identify PTSD risk in 2018.
As a veteran-owned business, our roots remain in our founding mission to improve the lives of US military service members & veterans living with behavioral health conditions, such as post-traumatic stress disorder (PTSD). In 2020, global public health events & an evolving behavioral health landscape revealed that the number of people standing to benefit from advances in diagnostics & treatment is broadening by the day.
Guided by a calling to serve, we expanded our mission to encompass:
- Veterans & active-duty US military service members,
- First responders, frontline workers, & individuals in high-risk occupations, &
- Trauma-exposed communities at large.
In 2017, inspired by their work at the Defense & Veterans Brain Injury Center & the US Department of Veterans Affairs, a veteran & a scientist coalesced their visions seeded in service around the urgent need for 21st-century innovation in behavioral healthcare. Drawing upon decades of experience in biomedical technology, public health, & molecular biology, they founded a company to take aim at the mental health crisis that results in 22 veteran suicides each day. Partnering with the Illumina Accelerator & scientists from Mount Sinai & the Max Planck Institute of Psychiatry, the team developed the first-to-market, patented genomic biomarker assay to identify PTSD risk in 2018.
As a veteran-owned business, our roots remain in our founding mission to improve the lives of US military service members & veterans living with behavioral health conditions, such as post-traumatic stress disorder (PTSD). In 2020, global public health events & an evolving behavioral health landscape revealed that the number of people standing to benefit from advances in diagnostics & treatment is broadening by the day.
Guided by a calling to serve, we expanded our mission to encompass:
- Veterans & active-duty US military service members,
- First responders, frontline workers, & individuals in high-risk occupations, &
- Trauma-exposed communities at large.
Location: United States, Maryland, Rockville
Employees: 11-50
Phone: +1 301-674-3253
Total raised: $100K
Founded date: 2017
Investors 2
| Date | Name | Website |
| - | TEDCO | tedcomd.co... |
| - | Endless Fr... | endlessfro... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 03.08.2022 | Grant | $100K | Maryland I... |
Mentions in press and media 4
| Date | Title | Description |
| 19.07.2022 | Polaris Genomics Announces Continued Research & $100K Grant Awarded from Maryland Industrial Partnership Program (MIPS) | As we continue to set our sights on better serving veterans, frontline workers & trauma-impacted communities, MIPS grants leverage crucial funding that accelerates genomics research outcomes.” — Polaris Genomics CEO Charles CathlinROCKV... |
| 06.05.2022 | Polaris Genomics among Endless Frontier Labs’ 21-22 Graduating Cohort of Groundbreaking Life Sciences Companies | Because of the importance of our mission, our executive team leans heavily into our military leadership experience and we spend significant time on team building and culture.” — Polaris Genomics CEO Charles CathlinNEW YORK, NY, UNITED STATE... |
| - | Polaris Genomics | “At the junction of medicine & behavioral health, Polaris Genomics harnesses the power of genomics to make invisible wounds like PTSD visible.” |
| - | Polaris Genomics | “Polaris Genomics is charting the course for researchers who want to bring biological clarity and objectivity to the assessment, diagnosis, and treatment of” |